Quick Search 
Drugs of the Future
Register or sign in

Drugs Fut 2005, 30(10): 1059
ISSN 0377-8282
Copyright 2005 Clarivate Analytics
CCC: 0377-8282
DOI: 10.1358/dof.2005.030.10.927377
Recent advances in the structural modification of ligustrazine: Cerebro- and cardiovascular activity of ligustrazine derivatives
Cheng, X.-C, Liu, X.-Y., Xu, W.-F.
Recent advances in the structural modification of ligustrazine and studies on the bioactivities of ligustrazine derivatives are reviewed in this article. Due to its rapid metabolism and short half-life, ligustrazine is not suitable for application in clinical practice. Derivatives of ligustrazine were therefore designed and synthesized, including ether, amine, amide, hydrocarbon and deuterated derivatives of ligustrazine and ester and alcohol derivatives of 2-hydroxymethyl-3,5,6-trimethylpyrazine, an active metabolite of ligustrazine. Some of these compounds present better cerebro- and cardiovascular activities and more favorable pharmacokinetic properties compared to the parent compound.

Full Text: HTMLPDF 

© Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy